Innovage Holding Revenue Growth Rates (INNV), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Innovage Holding Corp   (NASDAQ: INNV)
 

INNV's Revenue Growth by Quarter and Year

Innovage Holding 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/INNV/growth
https://api.csimarket.com/api/v1/companies/INNV/fundamentals
https://api.csimarket.com/api/v1/companies/INNV/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
INNV Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter June -
3rd Quarter March -
2nd Quarter December -
1st Quarter September 264.76
FY 264.76

INNVs Annual Revenue
Innovage Holding 's Revenue in the fiscal year 2026 $ 989.71 millions
Innovage Holding 's Revenue in the fiscal year 2025 $ 853.70 millions
Innovage Holding 's Revenue in the fiscal year 2024 $ 763.86 millions
Innovage Holding 's Revenue in the fiscal year 2023 $ 688.09 millions
Innovage Holding 's Revenue in the fiscal year 2022 $ 698.64 millions




INNV Revenue first quarter 2026 Y/Y Growth Comment
Innovage Holding Corp reported Revenue increase of 12.13% year on year in the first quarter 2026, to $ 264.76 millions, this is lower than Innovage Holding Corp 's recent average Revenue surge of 237.64%.

Looking into first quarter 2026 results within Medical Equipment & Supplies industry 124 other companies have achieved higher Revenue growth. While Innovage Holding Corp ' s Revenue growth of 12.13% ranks overall at the positon no. 2348 in the first quarter 2026.


INNV Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter June -
3rd Quarter March -
2nd Quarter December -
1st Quarter September 12.13 %
FY   -

Financial Statements
Innovage Holding 's first quarter 2026 Revenue $ 264.76 millions INNV's Income Statement
Innovage Holding 's first quarter 2025 Revenue $ 236.11 millions Quarterly INNV's Income Statement


INNV Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter June -
3rd Quarter March -
2nd Quarter December -
1st Quarter September 1.07 %
FY (Year on Year)   -


Back to INNV Growth rate Comparisons >> Back to INNV Growth rate Comparisons >>


Revenue first quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #125
Healthcare Sector #338
Overall #2348

Revenue Y/Y Growth Statistics
High Average Low
2589.15 % 237.64 % -28.58 %
(Mar 31 2021)   (Dec 31 2015)
Revenue first quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #125
Healthcare Sector #338
Overall #2348
Revenue Y/Y Growth Statistics
High Average Low
2589.15 % 237.64 % -28.58 %
(Mar 31 2021)   (Dec 31 2015)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Innovage Holding 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
3562.05 % 145.98 % -58.08 %
(Dec 31 2013)  


INNV's I. Quarter Q/Q Revenue Comment
Innovage Holding Corp achieved in the I. Quarter 2026 below company average Revenue growth of 1.07% quarter on quarter, to $ 264.76 millions.

Within Medical Equipment & Supplies industry 50 other companies have achieved higher Revenue quarter on quarter growth. While Innovage Holding 's Revenue growth quarter on quarter, overall rank is 1246.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #51
Healthcare Sector #180
Overall #1246
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #51
Healthcare Sector #180
Overall #1246
Revenue Q/Q Growth Statistics
High Average Low
3562.05 % 145.98 % -58.08 %
(Dec 31 2013)  


INNV's I. Quarter Q/Q Revenue Comment
Innovage Holding Corp achieved in the I. Quarter 2026 below company average Revenue growth of 1.07% quarter on quarter, to $ 264.76 millions.

Within Medical Equipment & Supplies industry 50 other companies have achieved higher Revenue quarter on quarter growth. While Innovage Holding 's Revenue growth quarter on quarter, overall rank is 1246.


Innovage Holding 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2026)		 12 Months Ending (Jun 30 2026) 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025)
Cumulative Revenue 12 Months Ending $ 1,018.36
Y / Y Revenue Growth (TTM) 15.11 %
Year on Year Revenue Growth Overall Ranking # 1331
Seqeuential Revenue Change (TTM) 2.89 %
Seq. Revenue Growth (TTM) Overall Ranking # 2354


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2026 period, Innovage Holding 's cumulative twelve months Revenue were $ 1,018 millions, company would post below average annual Revenue growth of 2.89% year on year, if the fiscal year would end at Sep 30 2026.
A slow-down in the Innovage Holding 's Revenue growth from the 261.95% growth in Jun 30 2026.

In the Healthcare sector 227 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 753 to 1331.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 125
Healthcare Sector # 228
Overall # 1331

Revenue TTM Y/Y Growth Statistics
High Average Low
2589.15 %
 237.64 %
-28.58 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 125
Sector # 338
S&P 500 # 2354
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2026 period, Innovage Holding 's cumulative twelve months Revenue were $ 1,018 millions, company would post below average annual Revenue growth of -28.58% year on year, if the fiscal year would end at Sep 30 2026.
A slow-down in the Innovage Holding 's Revenue growth from the 261.95% growth in Jun 30 2026.

In the Healthcare sector 227 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 753 to 1331.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 125
Healthcare Sector # 228
Overall # 1331

Revenue TTM Y/Y Growth Statistics
High Average Low
2589.15 %
237.64 %
-28.58 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 125
Sector # 338
S&P 500 # 2354




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
INNV's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Anteris Technologies Global Corp 20.98%$ 20.979 millions
Trisalus Life Sciences Inc 20.81%$ 20.807 millions
Orthopediatrics Corp20.55%$ 20.551 millions
Alpha Pro Tech Ltd 19.73%$ 19.729 millions
Insulet Corporation19.21%$ 19.213 millions
Abcellera Biologics Inc 18.81%$ 18.805 millions
Schrodinger Inc 18.72%$ 18.715 millions
Procept Biorobotics Corporation18.41%$ 18.414 millions
Supernus Pharmaceuticals inc 18.05%$ 18.047 millions
Harvard Apparatus Regenerative Technology Inc 17.89%$ 17.886 millions
Outset Medical Inc 17.51%$ 17.510 millions
Alnylam Pharmaceuticals Inc 16.74%$ 16.738 millions
IMPACT BIOMEDICAL INC.16.67%$ 16.667 millions
Rigel Pharmaceuticals Inc16.45%$ 16.452 millions
Si bone inc 16.42%$ 16.424 millions
Ars Pharmaceuticals Inc 16.03%$ 16.027 millions
Atricure Inc 15.84%$ 15.839 millions
American Shared Hospital Services15.76%$ 15.761 millions
Ardelyx inc 15.70%$ 15.704 millions
Novocure Limited15.67%$ 15.666 millions
Penumbra Inc15.64%$ 15.636 millions
Orasure Technologies Inc15.45%$ 15.445 millions
Electromed Inc 15.34%$ 15.342 millions
Irhythm Holdings Inc 15.34%$ 15.339 millions
P3 Health Partners Inc 14.80%$ 14.798 millions
Msa Safety Inc14.72%$ 14.716 millions
Ensign Group Inc14.47%$ 14.471 millions
Abbott Laboratories14.46%$ 14.460 millions
Electrocore Inc 14.40%$ 14.404 millions
Allogene Therapeutics Inc 14.29%$ 14.286 millions


About Innovage Holding Revenue Growth Rates (INNV), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.